Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds

Drug Delivery and Translational Research

Volumn 1, Issue 1, 2011, Pages 91-101

  Avilés, Misael O ^a   Shea, Lonnie D ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alginate; Biomaterial scaffolds; Collagen; Fibrin; Hydrogels; Lentivirus

Indexed keywords

ALGINIC ACID; COLLAGEN; FIBRIN; TISSUE SCAFFOLD; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HYDROGEL; IN VIVO STUDY; LENTIVIRINAE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SPLEEN; THYMUS; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM;

EID: 80054059518     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-010-0011-1     Document Type: Article

References (40)

1. Ali OA, Huebsch N, Cao L, Dranoff G, Mooney DJ. Infection-mimicking materials to program dendritic cells in situ. Nat Mater. 2009; 8: 151-8.
2. Alvarez D, Vollmann EH, von Andrian UH. Mechanisms and consequences of dendritic cell migration. Immunity. 2008; 29: 325-42.
3. Ameer GA, Mahmood TA, Langer R. A biodegradable composite scaffold for cell transplantation. J Orthop Res. 2002; 20: 16-9.
4. Avilés MO, Lin C-H, Zelivyanskaya M, Graham JG, Boehler RM, Messersmith PB, et al. The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds. Biomaterials. 2010; 31: 1140-7.
5. Babensee JE. Interaction of dendritic cells with biomaterials. Semin Immunol. 2008; 20: 101-8.
6. Babensee JE, Anderson JM, McIntire LV, Mikos AG. Host response to tissue engineered devices. Adv Drug Deliv Rev. 1998; 33: 111-39.
7. Blomeier H, Zhang X, Rives C, Brissova M, Hughes E, Baker M, et al. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation. 2006; 82: 452-9.
8. Chan AW, Neufeld RJ. Modeling the controllable pH-responsive swelling and pore size of networked alginate based biomaterials. Biomaterials. 2009; 30: 6119-29.
9. De Laporte L, Shea LD. Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev. 2007; 59: 292-307.
10. De Laporte L, Yan AL, Shea LD. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials. 2009; 30: 2361-8.
11. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003; 24: 4337-51.
12. Fisher JP, Eyrich D, Göpferich A, Blunk T. Fibrin in tissue engineering. In: Back N, Cohen IR, Kritchevsky D, Lajtha A, Paoletti R, editors. Tissue engineering. New York: Springer; 2007. p. 379-92.
13. Gong Y, He L, Li J, Zhou Q, Ma Z, Gao C, et al. Hydrogel-filled polylactide porous scaffolds for cartilage tissue engineering. J Biomed Mater Res B. 2007; 82: 192-204.
14. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater. 2005; 4: 518-24.
15. Hubbell JA, Thomas SN, Swartz MA. Materials engineering for immunomodulation. Nature. 2009; 462: 449-60.
16. Jang JH, Rives CB, Shea LD. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther. 2005; 12: 475-83.
17. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979; 11: 447-55.
18. Karp JM, Sarraf F, Shoichet MS, Davies JE. Fibrin-filled scaffolds for bone-tissue engineering: an in vivo study. J Biomed Mater Res A. 2004; 71: 162-71.
19. Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev. 2007; 59: 207-33.
20. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R. Novel approach to fabricate porous sponges of poly(-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials. 1996; 17: 1417-22.
21. Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci. 2007; 32: 762-98.
22. Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng B Rev. 2008; 14: 149-65.
23. Nielsen LF, Moe D, Kirkeby S, Garbarsch C. Sirius red and acid fuchsin staining mechanisms. Biotech Histochem. 1998; 73: 71-7.
24. Pannier AK, Shea LD. Controlled release systems for DNA delivery. Mol Ther. 2004; 10: 19-26.
25. Petter-Puchner AH, Simunek M, Redl H, Puchner KU, Griensven MV. A comparison of a cyanaocrylate glue (Glubran) vs. fibrin sealant (Tisseel) in experimental models of partial pulmonary resection and lung incison in rabbits. J Invest Surg. 2010; 23: 40-7.
26. Putnam D. Polymers for gene delivery across length scales. Nat Mater. 2006; 5: 439-51.
27. Raut SD, Lei P, Padmashali RM, Andreadis ST. Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays. J Control Release. 2010; 144: 213-20.
28. Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 2006; 27: 573-9.
29. Rives CB, Rieux Ad, Zelivyanskaya M, Stock SR, Lowe Jr WL, Shea LD. Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials. 2009; 30: 394-401.
30. Salvay DM, Rives CB, Zhang X, Chen F, Kaufman DB, Lowe Jr WL, et al. Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation. 2008; 85: 1456-64.
31. Salvay DM, Zelivyanskaya M, Shea LD. Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds. Gene Ther. 2010; 17: 1134-41.
32. Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol. 1999; 17: 551-4.
33. Shepard JA, Huang A, Shikanov A, Shea LD. Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels. J Control Release. 2010; 146: 128-35.
34. Shin S, Shea LD. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther. 2010; 18: 700-6.
35. Shin S, Salvay DM, Shea LD. Lentivirus delivery by adsorption to tissue engineering scaffolds. J Biomed Mater Res. 2010a; 93: 1252-9.
36. Shin S, Tuinstra HM, Salvay DM, Shea LD. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials. 2010b; 31: 4353-9.
37. Stachelek SJ, Song C, Alferiev I, Defelice S, Cui X, Connolly JM, et al. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther. 2004; 11: 15-24.
38. Tsui LV, Kelly M, Zayek N, Rojas V, Ho K, Ge Y, et al. Production of human clotting factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nat Biotechnol. 2002; 20: 53-7.
39. Yang YL, Motte S, Kaufman LJ. Pore size variable type I collagen gels and their interaction with glioma cells. Biomaterials. 2010; 31: 5678-88.
40. Zhang X-Q, Tang H, Hoshi R, De Laporte L, Qiu H, Xu X, et al. Sustained transgene expression via citric acid-based polyester elastomers. Biomaterials. 2009; 30: 2632-41.